Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2023

Oct 3, 2023

34412_dirs_2023-10-02_98a71e73-8412-461f-b278-c8ada56cbe7e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2023-09-28

Reporting Person: Schor Chen (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-09-28 Common Stock S 5500 $1.42 Disposed 37969 Indirect
2023-09-28 Common Stock P 5500 $1.42 Acquired 182469 Direct
2023-09-29 Common Stock S 5500 $1.3601 Disposed 176969 Direct
2023-10-02 Common Stock P 5500 $1.3345 Acquired 43469 Indirect
2023-10-02 Common Stock F 23208 $1.37 Disposed 153761 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 53424 Indirect

Footnotes

F1: The transactions reported herein were matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Reporting Person will promptly and voluntarily disgorge to the Issuer the full amount of the resulting statutory profit calculated pursuant to Section 16(b) of the Exchange Act.

F2: Represents shares held directly by The I. Schor IRRV Trust, an irrevocable family trust having an independent trustee.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $1.33 to $1.38, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the Securities and Exchange Commission ("SEC") staff upon request.

F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $1.32 to $1.35, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

F5: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

F6: Represents shares held directly by The C. Schor IRRV Trust, an irrevocable family trust having an independent trustee.